Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Colin Richman

Company director, Rx-Info Ltd, Exeter

Recent stories

  • Monopoly generic pricing in secondary careSubscription

    15 JUN 2016

    A story published in The Times on 3 June 2016 (Extortionate’ prices add £260m to NHS drug bill’), subsequently followed up by the BBC, has put the spotlight on monopoly generic drug pricing. Billy Kenber, who wrote the article, indicated that the data upon which the article was based were from primary care alone. As a result, Rx-info, an Exeter-based pharmaceutical research and development company, analysed generic medicines use in more than 90% of acute NHS hospital tr

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.